Home » Business » Manufacturing
R&D center for animal vaccine
March 13, 2012, Tuesday
|
Print Edition
Print Edition
GERMAN drugmaker Boehringer Ingelheim yesterday said it will invest 12 million euros (US$15.7 million) to set up its Asian Veterinary Research & Development Center in Shanghai to boost animal vaccine business.
The research facility will be located in Zhangjiang High-Tech Park and will focus on innovative vaccines targeted at specific diseases in swine and poultry.
It is the first animal health R&D facility set up by a global drug firm in China, and it's the third one for the company outside Germany and the United States.
(Cathy Ding)
The research facility will be located in Zhangjiang High-Tech Park and will focus on innovative vaccines targeted at specific diseases in swine and poultry.
It is the first animal health R&D facility set up by a global drug firm in China, and it's the third one for the company outside Germany and the United States.
(Cathy Ding)
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
